Erratum: [Corrigendum] Efficacy of transarterial chemoembolization-hepatic arterial infusion chemotherapy combined with targeted therapy and immunotherapy in hepatocellular carcinoma with portal vein tumor thrombosis.
[This corrects the article DOI: 10.3892/ol.2025.15109.].
APA
Hou X, Xu Q, et al. (2026). Erratum: [Corrigendum] Efficacy of transarterial chemoembolization-hepatic arterial infusion chemotherapy combined with targeted therapy and immunotherapy in hepatocellular carcinoma with portal vein tumor thrombosis.. Oncology letters, 31(4), 120. https://doi.org/10.3892/ol.2026.15473
MLA
Hou X, et al.. "Erratum: [Corrigendum] Efficacy of transarterial chemoembolization-hepatic arterial infusion chemotherapy combined with targeted therapy and immunotherapy in hepatocellular carcinoma with portal vein tumor thrombosis.." Oncology letters, vol. 31, no. 4, 2026, pp. 120.
PMID
41660274
Abstract
[This corrects the article DOI: 10.3892/ol.2025.15109.].
같은 제1저자의 인용 많은 논문 (5)
- The SDC1-ENO1 Axis in Cancer-Associated Fibroblasts Generates a Lactate-Rich Microenvironment that Drives Tumor Radioresistance.
- Evaluation of the accuracy of cone-beam CT-based dose calculation for target volumes and organs at risk in left-sided breast cancer radiotherapy.
- Combination of locoregional and systemic therapy for hepatocellular carcinoma with portal vein tumor thrombus: a real-world retrospective study.
- Xiao-Yao-San suppresses psychological distress-related colorectal cancer metastasis and enhances antitumor immune responses through regulating gut microbiota-bile acid axis.
- A case report of hemophagocytic lymphohistiocytosis occurring during ibrutinib chemotherapy with a literature review.